Loading…
Perrigo Company plc is projected to rise to $10.83 by 2027, a +6% move from its current price of $10.22. PRGO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 15 | $9.96 | $10.22 | $10.50 | +0.04% |
| Jul 16 | $9.85 | $10.23 | $10.62 | +0.08% |
| Jul 17 | $9.78 | $10.23 | $10.71 | +0.13% |
| Jul 18 | $9.71 | $10.24 | $10.79 | +0.17% |
| Jul 19 | $9.65 | $10.24 | $10.86 | +0.21% |
| Jul 20 | $9.60 | $10.25 | $10.93 | +0.25% |
| Jul 21 | $9.56 | $10.25 | $10.99 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.56 | $10.25 | $10.99 | +0.30% |
| Week 2 | $9.31 | $10.28 | $11.35 | +0.59% |
| Week 3 | $9.14 | $10.31 | $11.64 | +0.89% |
| Week 4 | $8.99 | $10.34 | $11.89 | +1.19% |
| Week 5 | $8.87 | $10.37 | $12.12 | +1.48% |
| Week 6 | $8.77 | $10.40 | $12.34 | +1.78% |
| Week 7 | $8.67 | $10.43 | $12.55 | +2.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments.
The company offers a broad portfolio that includes upper respiratory products, nutrition products, digestive health, pain and sleep-aids, oral care, healthy lifestyle, skin care, women's health, vitamins, minerals, and supplements, and other self-care products. It sells its products under brands such as Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed.
The company also offers contract manufacturing services.
It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The Perrigo Company plc name was adopted in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Perrigo Company plc (PRGO) is a healthcare company focused on over-the-counter health and wellness solutions with a global reach. It operates through two segments: Consumer Self-Care Americas and Consumer Self-Care International.
The current price is $10.22 and the reported market cap is $1.41B, with a market ranking of 2307. The stock trades in a market consistent with a smaller-cap healthcare name and presents a defined near-term technical setup alongside a long-run forecast path.
Near term, the stock shows a neutral price trajectory with a 30-day range that reflects modest volatility, bounded by support around $9.49 and resistance near $11.61. The present price surroundings and the forecast series suggest a gradual path upward in the longer term, contingent on continued market conditions and company performance.
A major floor 18.6% below — a decisive break under it would weaken the trend.
The nearest floor, 7.1% below — buyers have tended to step in here.
The nearest ceiling, 13.6% above — a clean break opens room to run.
A major ceiling 22.9% above — clearing it would confirm fresh momentum.
Key PRGO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PRGO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.69 | Sell | $10.49 | Sell |
| MA 10 | $10.52 | Sell | $10.49 | Sell |
| MA 20 | $10.37 | Sell | $10.50 | Sell |
| MA 50 | $10.85 | Sell | $10.78 | Sell |
| MA 100 | $11.10 | Sell | $11.62 | Sell |
| MA 200 | $13.71 | Sell | $14.05 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.04 | Neutral |
| Stoch RSI (14) | 46.93 | Neutral |
| CCI (20) | -23.38 | Neutral |
| Williams %R (14) | -57.06 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 7.69 | Buy |
| Bollinger %B (20,2) | 0.43 | Neutral |
| Stochastic %K (14) | 42.94 | Neutral |
| TRIX (15) | -0.19 | Sell |
| Awesome (5,34) | 0.05 | Buy |
| Ultimate (7,14,28) | 46.55 | Neutral |
| Momentum (10) | 0.54 | Buy |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 10.53 | Sell |
| ADX (14) | 12.83 | Neutral |
| ATR (14) | 0.26 | Info |
Near term, sentiment is NEUTRAL with RSI(14) at 50. The 50-day simple moving average sits at $10.85, while the 200-day simple moving average sits at $13.71, indicating a balance between short-term momentum and longer-term valuation.
The 30-day range is $8.59 to $12.16, outlining a relatively wide yet contained swing band. Support is identified at $9.49 and resistance at $11.61, framing a narrow trading corridor in the immediate horizon.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.25 | $10.22 | $13.00 | 0% | Neutral | |
| $8.65 | $10.83 | $14.33 | +6% | Neutral | |
| $8.49 | $10.92 | $14.98 | +7% | Neutral | |
| $8.88 | $11.67 | $16.46 | +14% | Neutral | |
| $8.70 | $11.67 | $16.85 | +14% | Neutral | |
| $9.43 | $12.88 | $18.99 | +26% | Bullish | |
| $11.27 | $15.64 | $23.50 | +53% | Bullish | |
| $11.98 | $16.89 | $25.80 | +65% | Bullish | |
| $12.11 | $17.33 | $26.89 | +70% | Bullish | |
| $11.89 | $17.26 | $27.17 | +69% | Bullish | |
| $17.06 | $26.41 | $44.15 | +158% | Bullish | |
| $24.31 | $42.00 | $76.66 | +311% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $9.25 | $10.22 | $12.16 | +0.00% |
| August 2026 | $8.72 | $10.28 | $12.43 | +0.57% |
| September 2026 | $8.95 | $10.62 | $12.99 | +3.33% |
| October 2026 | $8.97 | $10.71 | $13.21 | +0.82% |
| November 2026 | $8.69 | $10.42 | $12.96 | -2.67% |
| December 2026 | $8.61 | $10.38 | $13.00 | -0.36% |
Click any year to see its month-by-month PRGO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PRGO is projected to trade between $9.25 and $13.00, averaging $10.22 — a potential gain of 0% from today's $10.22. A consolidation phase looks the most probable path here.
Perrigo Company plc's 2027 outlook centres on $10.83, within a $8.65 to $14.33 range. That is up +6% on the projected 2026 average. That marks a +6% change versus current levels. Price action looks broadly range-bound.
By 2028, PRGO could reach as high as $14.98, with a base case around $10.92 and support toward $8.49 — roughly +7% from $10.22. A consolidation phase looks the most probable path here.
Expect PRGO to range from $8.88 to $16.46 through 2029. The $11.67 average target implies a +14% move from current prices. That is up +7% on the projected 2028 average. Price action looks broadly range-bound.
The PRGO price prediction for 2030 points to an average of $11.67 (low $8.70, high $16.85) — a potential gain of +14% on today's $10.22. A consolidation phase looks the most probable path here.
In 2031, PRGO is projected to trade between $9.43 and $18.99, averaging $12.88 — a potential gain of +26% from today's $10.22. That is up +10% on the projected 2030 average. Momentum favours further upside here.
Perrigo Company plc's 2032 outlook centres on $15.64, within a $11.27 to $23.50 range. That is up +21% on the projected 2031 average. That marks a +53% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PRGO could reach as high as $25.80, with a base case around $16.89 and support toward $11.98 — roughly +65% from $10.22. Momentum favours further upside here.
Expect PRGO to range from $12.11 to $26.89 through 2034. The $17.33 average target implies a +70% move from current prices. That is up +3% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The PRGO price prediction for 2035 points to an average of $17.26 (low $11.89, high $27.17) — a potential gain of +69% on today's $10.22. Momentum favours further upside here.
In 2040, PRGO is projected to trade between $17.06 and $44.15, averaging $26.41 — a potential gain of +158% from today's $10.22. That is up +53% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Perrigo Company plc's 2050 outlook centres on $42.00, within a $24.31 to $76.66 range. That is up +59% on the projected 2040 average. That marks a +311% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PRGO today (≈ 97.847358 PRGO) could be worth
$4,109.32
+$3,109.32 (+311%) by 2050 · US Dollar
Based on the average projected PRGO price of $42 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PRGOwould be worth at today's price.
$1,000 invested in PRGO on Jul 10, 2025 (≈ 36.670333 PRGO) would be worth
$374.77
-$625.23 (-62.5%) today · 0.37× · US Dollar
Based on a PRGO entry price of $27.27 vs. today's $10.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.02 | $927.4 | -7.3% |
| 1 month ago | $11.17 | $914.95 | -8.5% |
| 3 months ago | $10.86 | $941.07 | -5.9% |
| 6 months ago | $14.94 | $684.07 | -31.6% |
| 1 year ago | $27.27 | $374.77 | -62.5% |
| All time (5.0y) ago | $46.31 | $220.69 | -77.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PRGO forecast.
Our base-case forecast reaches $20.00 around 2040.
Implied market cap at $20.00: $2.77B
The year-by-year forecast shows a neutral stance in 2026 with an average price of $10.22 and a range from $9.25 to $13.01. By 2027–2029, the average price trends higher modestly, with 2027 at $10.84, 2028 at $10.91, and 2029 at $11.68, while returns remain in the low-to-mid single digits in ROI terms.
A material shift occurs starting 2031, when sentiment turns BULLISH and the average price rises to $12.87. The forecast continues to climb through 2032–2035, with averages of $15.67, $16.88, $17.31, and $17.29 respectively, and ROI expanding from 25.9% to 69.1% across this period.
By 2040, the average price is projected at $26.41 with a max of $44.14 and an ROI of 158.4%. The long-run view extends to 2050, where the average is $42.02, the max reaches $76.71, and ROI peaks at 311.2%. These figures reflect a sustained bullish trajectory in the later years, balanced against early-year volatility and potential near-term headwinds.
Overall, the longer-range outlook shows a pronounced upcycle from 2031 onward, subject to market conditions and company performance. The forecast highlights a meaningful rise in value by 2050, but the path includes periods of volatility and uncertainty, and these are estimates, not guarantees.
Tap a question to reveal the answer.
Average price is $11.67, with a minimum of $8.70 and a maximum of $16.85. ROI is 14.1%, and sentiment is NEUTRAL.
Starting in 2031, the sentiment is BULLISH, with 2031 average $12.87 and a range up to $18.98. ROI in 2031 is 25.9%.
Current price is $10.22 and market cap is $1.41B. The company ranks 2307 by market capitalization.
Average price $42.02, minimum $24.33, maximum $76.71, with ROI of 311.2% and sentiment BULLISH.
RSI(14) is 50, SMA50 is $10.85, SMA200 is $13.71. The 30-day range is $8.59 to $12.16, with near-term support at $9.49 and resistance at $11.61.
Perrigo Company plc Community Discussion
0Share your Perrigo Company plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.